@Melody432 Unbelievably, some of the EPS consensus estimates have improved since the Q1 revenue downgrade which confirms your theory that there must be a calculator shortage. Some analysts don't deserve any credibility.
The following report has at least gone the right way but there's at least one analyst who needs to look for another job:
All they had to do was read the announcement (I think this is where some must go wrong) and see that revenue is expected to be ~$4.05M lower than what the revenue they should've been working on for Q1 ($15.2M), and adjust accordingly e.g.,
Previous EPS consensus: -0.42
+
Q1 adjustment: -0.16 (-$4.05M/25.6M)
= -0.58 (new peak in opex/revenue)
If we say -0.58 is right and consensus doesn't change over the next few weeks, they're looking at a:
- 30% miss on -0.445
- 93% miss on -0.30
- 123% miss on -0.26
Ann: AVITA Medical Q4 2023 Investor Presentation, page-44
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.12 |
Change
-0.050(1.58%) |
Mkt cap ! $219.7M | |||
| Open | High | Low | Value | Volume |
| $3.15 | $3.15 | $3.09 | $174.0K | 55.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 221 | $3.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.13 | 399 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |